$100.99 -2.67 (%) Gilead Sciences Inc - NASDAQ

Sep. 15, 2014 | 04:15 PM

Partner Headlines

  1. Gilead to license Sovaldi

    IBD | Sep. 15, 2014 | 18:53PM EST
  2. Gilead OKs Generic Sovaldi To Expand Global Access

    IBD | Sep. 15, 2014 | 11:35AM EST
  3. Morning Market Losers

    Benzinga | Sep. 15, 2014 | 09:48AM EST
  4. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 15, 2014 | 08:15AM EST
  5. #PreMarket Primer: Monday, September 15: Cameron Vows To Destroy ISIS

    Benzinga | Sep. 15, 2014 | 07:54AM EST
  6. Mylan In Pact With Gilead To Accelerate Access To Hepatitis C

    Benzinga | Sep. 15, 2014 | 06:31AM EST
  7. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD | Sep. 13, 2014 | 08:02AM EST
  8. 5 Top Stocks With Rising Earnings Estimates

    IBD | Sep. 12, 2014 | 08:02AM EST
  9. Stocks Bounce As Nasdaq, S&P 500 Close With Small Gains

    IBD | Sep. 11, 2014 | 16:17PM EST
  10. Stocks Show Modest Losses; Biotechs Pressured Again

    IBD | Sep. 11, 2014 | 14:46PM EST
  11. Gilead Sciences, Inc. Could Be Taking A Break Before Even More Upside

    Benzinga | Sep. 10, 2014 | 15:05PM EST
  12. Stocks Turn Higher After Soft Start; U.S. Silica Jumps

    IBD | Sep. 10, 2014 | 13:25PM EST
  13. Stocks Up At Midday; Alexion Leads Biotech Rebound

    IBD | Sep. 10, 2014 | 11:54AM EST
  14. Under Armour, Apple, Gilead Among Big-Cap Leaders

    IBD | Sep. 10, 2014 | 08:02AM EST
  15. Pharmacyclics Price Target Cut On Higher Spending

    IBD | Sep. 8, 2014 | 13:02PM EST
  16. CNBC's Stock Pops & Drops From September 5

    Benzinga | Sep. 6, 2014 | 18:32PM EST
  17. CNBC's Stock Pops & Drops From September 5: Control4 Corp, Priceline Group Inc & More

    Benzinga | Sep. 6, 2014 | 18:32PM EST
  18. Allianz's Analyst Likes Biogen, Celgene & Gilead

    Benzinga | Sep. 6, 2014 | 17:28PM EST
  19. Fast Money Halftime Report Final Trade From September 5

    Benzinga | Sep. 6, 2014 | 17:26PM EST
  20. Meet 5 IBD 50 Stocks Expanding Into New Markets

    IBD | Sep. 6, 2014 | 08:01AM EST
  21. Gilead Dips On Cheap Drugs

    IBD | Sep. 5, 2014 | 19:24PM EST
  22. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD | Sep. 5, 2014 | 17:06PM EST
  23. Why Gilead Is Falling On Drugs For Developing Nations

    IBD | Sep. 5, 2014 | 15:15PM EST
  24. Indexes Trim Losses But Remain Lower At Midday

    IBD | Sep. 5, 2014 | 12:04PM EST
  25. Stocks Sag In Light Trade; Taser Bolts Higher, Gilead Dips

    IBD | Sep. 5, 2014 | 10:33AM EST
  26. A Word On Healthcare Mutual Funds, And One Sector's 'Fittest' Segment

    Benzinga | Sep. 5, 2014 | 10:22AM EST
  27. Markets Edge Lower; Zumiez Issues Weak Outlook

    Benzinga | Sep. 5, 2014 | 10:21AM EST
  28. Why Gilead Sciences, Inc. Is A Top Mutual Fund Holding

    Benzinga | Sep. 5, 2014 | 09:27AM EST
  29. New Managers Revive Thrivent Large Cap Growth Fund

    IBD | Sep. 3, 2014 | 18:28PM EST
  30. Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead

    IBD | Sep. 3, 2014 | 18:28PM EST
  31. Infinity Pharma Joins AbbVie On Blood Cancer Drug

    IBD | Sep. 3, 2014 | 13:20PM EST
  32. Biotechnology, Oil And Brazil ETFs To Watch This Week

    Benzinga | Sep. 2, 2014 | 10:05AM EST
  33. Mike Khouw's Gilead Sciences Trade

    Benzinga | Aug. 30, 2014 | 11:20AM EST
  34. What You Need to Know About the Roche-InterMune Deal

    Benzinga | Aug. 29, 2014 | 15:51PM EST
  35. 4 Biotechs That Might Be Bought Soon

    IBD | Aug. 29, 2014 | 11:53AM EST
  36. Bristol-Myers Drug Gets OK

    IBD | Aug. 27, 2014 | 18:56PM EST
  37. Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)

    Benzinga | Aug. 27, 2014 | 15:22PM EST
  38. After Reaching All-Time Highs, How Can Gilead Sciences Continue growing?

    GuruFocus | Aug. 27, 2014 | 15:06PM EST
  39. Bristol-Myers Hepatitis C Therapy Approved in EU

    IBD | Aug. 27, 2014 | 12:03PM EST
  40. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD | Aug. 27, 2014 | 08:02AM EST
  41. #PreMarket Primer: Wednesday, August 27: Israel And Hamas To Resume Peace Talks In Cairo

    Benzinga | Aug. 27, 2014 | 07:08AM EST
  42. Celgene rose 2.4%

    IBD | Aug. 26, 2014 | 18:45PM EST
  43. Stocks Rise As Biotechs Lead; Amazon To Buy Twitch

    IBD | Aug. 26, 2014 | 16:58PM EST
  44. Celgene, Gilead Lead Big Biotech Stock Movers

    IBD | Aug. 26, 2014 | 14:38PM EST
  45. Meet 5 Leading Stocks That Big Funds Are Buying

    IBD | Aug. 26, 2014 | 08:02AM EST
  46. #PreMarket Primer: Tuesday, August 26: US Gathers Intelligence In Syria

    Benzinga | Aug. 26, 2014 | 06:37AM EST
  47. Biogen, Celgene In Buy Range; LinkedIn Coming Back

    IBD | Aug. 25, 2014 | 18:43PM EST
  48. Why Some Low-Volume Breakouts Can Still Work

    IBD | Aug. 25, 2014 | 18:16PM EST
  49. Stocks Rise As Biotechs Lead; Amazon To Buy Twitch

    IBD | Aug. 25, 2014 | 16:58PM EST
  50. Stocks Higher With Biotechs Leading The Way

    IBD | Aug. 25, 2014 | 16:34PM EST
Trading Center